Latest Asx News

Falcon Metals has reported a spectacular high-grade gold intersection of 1.2 metres at 543 g/t from its first wedge hole at the Blue Moon Prospect, confirming the potential for Bendigo-style mineralisation in Victoria’s historic goldfield.

HITIQ Limited is set to debut its PROTEQT concussion management system in the UK on August 4, 2025, uniquely integrating with NHS 111 telehealth services to offer free medical guidance. This launch marks HITIQ’s first international consumer market entry and a strategic step in its global expansion.

Sunshine Metals has completed resource infill drilling at its Plateau gold-silver prospect and reconnaissance drilling at the Salla gold-copper-zinc prospect, delivering results that support an upcoming resource update and further exploration.

Environmental Clean Technologies Limited (ECT) plans a 15-to-1 capital consolidation to streamline its share structure and attract broader investor interest, pending shareholder approval in August 2025.

Almonty Industries has had its trading suspension lifted following the release of an updated technical report on its Sangdong Project in South Korea, signaling renewed investor access and potential project reassessment.

RBR Group Limited has launched a Share Purchase Plan to raise up to $650,000, offering eligible shareholders shares at a notably low price of $0.001 each. The funds will support a joint venture, repay convertible notes, and bolster working capital.

Titan Minerals has reported significant high-grade gold and silver mineralisation from surface trenching at its Cerro Verde prospect, bolstering confidence ahead of a mineral resource update expected in late Q3 2025.

Red Mountain Mining reports promising gold assays at Oaky Creek and announces a fully funded trenching and soil sampling program to advance its Armidale Antimony-Gold project.

Service Stream Limited has extended its contract with NBN Co to continue upgrading the ACT’s fibre network, securing $360 million in revenue over 3.5 years.

Invion Limited’s IVXO securities have been suspended from ASX quotation due to non-compliance with key listing rules, raising questions about the company’s regulatory standing and investor confidence.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Kingston Resources has received the first $50 million payment from the sale of its Misima Gold Project, bolstering its balance sheet and enabling a strategic pivot towards expanding its Australian copper operations.